Modifiable Risk Factors associated with Post-Operative Bleeding and transfusion requirements in Cardiac Surgery

Bahauddin Khan, Mujahid Ul Islam, Imtiaz Ahmad, Mujeeb Ur Rehman, Bahauddin Khan, Mujahid Ul Islam, Imtiaz Ahmad, Mujeeb Ur Rehman

Abstract

Objectives: In this study we determine the modifiable factors related to bleeding and transfusion in post-cardiac surgery patients who underwent open heart surgery.

Methods: This is a retrospective study that include two hundred patients who had undergone open heart surgery (OHS) at Northwest General Hospital and Research Center from December 2018 to July 2021. Platelet count and hemoglobin level were measured in the pre-operative period.

Results: This study included both male and female patients. Postoperative platelets were counted as follow: 50-100 x109 L in 3.0% cases, 101-150 x109 L seen in 27.5% cases, and >150 x 109 L in 69.5% cases which required transfusion. We have also reported the increased requirement of transfusion of blood and blood products in patients with pre-operative hemoglobin (Hb) < 10 g/dl.

Conclusion: Correction of pre-op Hb, post-op platelet count and total bypass time are the significant and preventable parameters in patients undergoing cardiac surgery if proper pre-op assessment of the patient is performed.

Keywords: Bleeding; Cardiopulmonary bypass; Hemoglobin; Open heart surgery; Platelets.

Conflict of interest statement

Conflicts of interest: None.

Copyright: © Pakistan Journal of Medical Sciences.

Figures

Fig.1
Fig.1
Procedures Breakup. Abbreviation: ASD: Atrial Septal Defect, VSD: Ventricular Septal Defect, AVR: Aortic Valve, Replacement, DVR: Double Valve Replacement, OPCABG: Off-Pump Coronary Artery Bypass Grafting, MVR: Mitral Valve Replacement, TC: Total Correction, REDO: Re-Opening cases
Fig.2
Fig.2
Association of Pre-Operative Hemoglobin Level with chest re-opening, post-op blood and blood products requirements’

References

    1. Choi YJ, Yoon SZ, Joo BJ, Lee JM, Jeon YS, Lim YJ, et al. Postoperative excessive blood loss after cardiac surgery can be predicted with International Society on Thrombosis and Hemostasis scoring system. Braz J Anesthesiol. 2017;67:508–515. doi:10.1016/j.bjane.2016.12.001.
    1. DeBois W, Liu J, Lee L, Girardi L, Ko W, Tortolani A, et al. Cardiopulmonary bypass in patients with pre-existing coagulopathy. J Extra Corpor Technol. 2005;37(1):15.
    1. McMillan D, Potger K, Southwell J. Blood management issues:getting clots together when you want them. J Extra Corpor Technol. 2011;43(1):P52.
    1. Richard WC, Harker LA. “Bleeding complications associated with cardiopulmonary bypass.”. Journal name is missing. 1990:1680–1697. doi:10.1182/blood.V76.9.1680.1680.
    1. Kremke M, Hansen MK, Christensen S, Tang M, Andreasen JJ, Jakobsen CJ. The association between platelet transfusion and adverse outcomes after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2015;48(5):e102–e129. doi:10.1093/ejcts/ezv297.
    1. Osei?Bimpong A, McLean R, Bhonda E, Lewis SM. The use of the white cell count and haemoglobin in combination as an effective screen to predict the normality of the full blood count. Int J Lab Hematol. 2012;34(1):91–107. doi:10.1111/j.1751-553X.2011.01365.x.
    1. Choong CK, Gerrard C, Goldsmith KA, Dunningham H, Vuylsteke A. Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes. Eur J Cardiothorac Surg. 2007;31(5):834–838. doi:10.1016/j.ejcts.2007.02.001.
    1. Frojd V, Jeppsson A. Reexploration for bleeding and its association with mortality after cardiac surgery. Ann Thorac Cardiovasc Surg. 2016;102(1):109–117. doi:10.1016/j.athoracsur.2016.01.006.
    1. Janiec M, Nazari Shafti TZ, Dimberg A, Lagerqvist B, Lindblom RP. Graft failure and recurrence of symptoms after coronary artery bypass grafting. Scand Cardiovasc J. 2018;52(3):113–119. doi:10.1080/14017431.2018.1442930.
    1. Whitson BA, Huddleston SJ, Savik K, Shumway SJ. Risk of adverse outcomes associated with blood transfusion after cardiac surgery depends on the amount of transfusion. J Surg Res. 2010;158(1):20–27. doi:10.1016/j.jss.2008.10.015.
    1. Davidson S. State of the A rt–How I manage coagulopathy in cardiac surgery patients. Br J Haematol. 2014;164(6):779–789. doi:10.1111/bjh.12746.
    1. Tettey M, Aniteye E, Sereboe L, Edwin F, Kotei D, Tamatey M, et al. Predictors of post operative bleeding and blood transfusion in cardiac surgery. Ghana Med J. 2009;43(2):71–76. doi:10.4314/gmj.v43i2.55316.
    1. Scott BH, Seifert FC, Glass PS, Grimson R. Blood use in patients undergoing coronary artery bypass surgery:impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg. 2003;97(4):958–963. doi:10.1213/01.ANE.0000081790.75298.D8.
    1. Janiec M, Dimberg A, Nazari Shafti TZ, Lagerqvist B, Lindblom RP. No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit:a Swedish nationwide registry study. Eur J Cardiothorac Surg. 2018;53(2):448–454. doi:10.1093/ejcts/ezx280.
    1. Pagano D, Milojevic M, Meesters MI, Benedetto U, Bolliger D, von Heymann C, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg. 2018;53(1):79–111. doi:10.1093/ejcts/ezx325.
    1. Ranucci M, Bozzetti G, Ditta A, Cotza M, Carboni G, Ballotta A. Surgical reexploration after cardiac operations:why a worse outcome? Ann Thorac Surg. 2008;86(5):1557–1562. doi:10.1016/j.athoracsur.2008.07.114.
    1. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V. Standardized bleeding definitions for cardiovascular clinical trials:a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736–2747. doi:10.1161/CIRCULATIONAHA.110.009449.
    1. Zhou X, Lui C, Whitman GJ. InCardiac Surgery. Springer, Cham; 2020. Bleeding and Re-exploration After Cardiac Surgery; pp. 763–768. doi:10.1007/978-3-030-24174-2_83.
    1. Hardy JF, Harel F, Belisle S. Transfusions in patients undergoing cardiac surgery with autologous blood. Can J Anaesth. 2000;47(7):705–711. 10.1007/BF03019006.
    1. Dyke C, Aronson S, Dietrich W, Hofmann A, Karkouti K, Levi M, et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg. 2014;147(5):1458–1463. doi:10.1016/j.jtcvs.2013.10.070.
    1. Lopes CT, Brunori EH, Cavalcante AM, Moorhead SA, Lopes JD, Barros AL. Predictors of red blood cell transfusion after cardiac surgery:A prospective cohort study. Revista da Escola de Enfermagem da USP. 2015;49:914–922. doi:10.1590/S0080-623420150000600006.
    1. Bolliger D, Lance MD, Siegemund M. Point-of-care platelet function monitoring:Implications for patients with platelet inhibitors in cardiac surgery. J Cardiothorac Vasc Anesth. 2021;35(4):1049–1059. doi:10.1053/j.jvca.2020.07.050.
    1. Corredor C, Wasowicz M, Karkouti K, Sharma V. The role of point?of?care platelet function testing in predicting postoperative bleeding following cardiac surgery:A systematic review and meta?analysis. Anaesthesia. 2015;70(6):715–731. doi:10.1111/anae.13083.
    1. Agarwal S, Johnson RI, Kirmani BH. Pre-and post-bypass platelet function testing with multiple electrode aggregometry and TEG platelet mapping in cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29(5):1272–1276. doi:10.1053/j.jvca.2015.01.028.
    1. Kehara H, Takano T, Ohashi N, Terasaki T, Amano J. Platelet function during cardiopulmonary bypass using multiple electrode aggregometry:comparison of centrifugal and roller pumps. Artif Organs. 2014;38(11):924–930. doi:10.1111/aor.12299.
    1. Ranucci M, Colella D, Baryshnikova E, Di Dedda U. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery. Br J Anaesth. 2014;113(6):970–976. doi:10.1093/bja/aeu315.
    1. Van Poucke S, Stevens K, Kicken C, Simons A, Marcus A, Lance M. Platelet function during hypothermia in experimental mock circulation. Artif Organs. 2016;40(3):288–293. doi:10.1111/aor.12555.
    1. Lax M, Pesonen E, Hiippala S, Schramko A, Lassila R, Raivio P. Heparin Dose and Point-of-Care Measurements of Hemostasis in Cardiac Surgery-Results of a Randomized Controlled Trial. J Cardiothorac Vasc Anesth. 2020;34(9):2362–2368. doi:10.1053/j.jvca.2019.12.050.
    1. Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D Surgical and Clinical Outcome Research (SCORE) Group. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg. 2011;91(1):123–129. doi:10.1016/j.athoracsur.2010.09.022.
    1. Haider Z, Jalal A, Alamgir AR, Rasheed I. Neurological complications are avoidable during CABG. Pak J Med Sci. 2018;34(1):5. doi:10.12669/pjms.341.14114.
    1. Ranucci M, Pistuddi V, Di Dedda U, Menicanti L, De Vincentiis C, Baryshnikova E. Platelet function after cardiac surgery and its association with severe postoperative bleeding:the platform study. Platelets. 2019;30(7):908–914. doi:10.1080/09537104.2018.1535706.
    1. Harker LA, Malpass TW, Branson HE, Hessel E, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass:Acquired transient platelet dysfunction associated with selective α-granule release. Blood. 1980;56(5):824–834. doi:10.1182/blood.V56.5.824.824.
    1. Perek B, Stefaniak S, Komosa A, Perek A, Katynska I, Jemielity M. Routine transfusion of platelet concentrates effectively reduces reoperation rate for bleeding and pericardial effusion after elective operations for ascending aortic aneurysm. Platelets. 2016;27(8):764–770. doi:10.1080/09537104.2016.1184748.
    1. Hamid M, Akhtar MI, Naqvi HI, Ahsan K. Incidence and pattern of thrombocytopenia in cardiac surgery patients. J Pak Med Assoc. 2017;67(7):1019–1023.
    1. Chow JH, Mazzeffi MA, Tanaka KA. Teaching an old dog new TRICS:re-evaluating transfusion triggers in high-risk cardiac surgery. J Thorac Dis. 2018;10(2):674–677. doi:10.21037/jtd.2018.01.78.
    1. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med. 1995;333(16):1025–1032. doi:10.1056/NEJM199510193331601.
    1. Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA. 1993;270(22):2699–2707. doi:10.1001/jama.1993.03510220055034.
    1. Horvath KA, Acker MA, Chang H, Bagiella E, Smith PK, Iribarne A, Kron IL, Lackner P, Argenziano M, Ascheim DD, Gelijns AC. Blood transfusion and infection after cardiac surgery. Ann. Thorac. Surg. 2013;95(6):2194–201. doi:10.1016/j.athoracsur.2012.11.078.
    1. Abukhodair AW, Alqarni MS, Bukhari ZM, Qadi Sr A, Mufti HN, Fernandez JA, et al. Association between post-operative infection and blood transfusion in cardiac surgery. Cureus. 2020;12(7) doi:10.7759/cureus.8985.
    1. Bhaskar B, Dulhunty J, Mullany DV, Fraser JF. Impact of blood product transfusion on short and long-term survival after cardiac surgery:More evidence. Ann Thorac Surg. 2012;94(2):460–467. doi:10.1016/j.athoracsur.2012.04.005.
    1. Tankard KA, Park B, Brovman EY, Bader AM, Urman RD. The impact of preoperative intravenous iron therapy on perioperative outcomes in cardiac surgery:A systematic review. Br J Haematol. 2020;9(4):97. doi:10.14740/jh696.
    1. Froessler B, Rueger AM, Connolly MP. Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany. Risk Manag Healthcare Policy. 2018;11:77. doi:10.2147/RMHP.S157379.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner